• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA (VOLUME/ADDITIVE UNKNOWN); IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA (VOLUME/ADDITIVE UNKNOWN); IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number UNK JUVEDERM VOLUMA-ADDITIVE
Device Problem Off-Label Use (1494)
Patient Problem Necrosis (1971)
Event Date 04/01/2020
Event Type  Injury  
Event Description
Healthcare professional reported a patient ordered juvéderm® voluma¿ over the internet and self-injected in the lips after viewing internet video tutorials.Following the injection, an adverse event of "persistent deformation of the lips for more than 20 months" was immediately noted.8 weeks following the injection, there was bruising and major oedema away from the injection site with "distension of the mucosa with persistent edema and loss of shape of the upper lip." patient also had social embarrassment after they performed the injection.Current state of the patient was noted no knowledge of the risks for "necrosis, cessation, deformations.".
 
Manufacturer Narrative
The filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event of necrosis is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional reported a patient ordered juvéderm® voluma¿ over the internet and self-injected in the lips after viewing internet video tutuorials.Following the injection, an adverse event of "persistent deformation of the lips for more than 20 months" was immediately noted.8 weeks following the injection, there was bruising and major oedema away from the injection site with "distension of the mucosa with persistent edema and loss of shape of the upper lip." patient also had social embarassment after they perfomed the injection.Current state of the patient was noted no knowledge of the risks for "necrosis, cessation, deformations.".
 
Event Description
Additional details received noting that 1ml of product was injected and packaged needle was used.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA (VOLUME/ADDITIVE UNKNOWN)
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
chris sprague
12331-a riata trace parkway
building 3
austin, TX 78727
8479375615
MDR Report Key13793537
MDR Text Key287352523
Report Number3005113652-2022-00143
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue NumberUNK JUVEDERM VOLUMA-ADDITIVE
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age50 YR
Patient SexFemale
-
-